Cardiff Oncology, Inc. - Common Stock (NQ:CRDF)
Price and Volume
Detailed Quote| Volume | 422,322 |
| Open | 2.110 |
| Bid (Size) | 2.100 (9,000) |
| Ask (Size) | 2.170 (200) |
| Prev. Close | 2.130 |
| Today's Range | 2.100 - 2.195 |
| 52wk Range | 1.900 - 5.639 |
| Shares Outstanding | 39,552,129 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
Cardiff Oncology (CRDF) Q2 Loss Down 19% ↗
July 30, 2025
Earnings Scheduled For February 27, 2025 ↗
February 27, 2025
These stocks are moving in today's pre-market session ↗
July 30, 2025
What's going on in today's after hours session ↗
July 29, 2025
Top movers in Tuesday's after hours session ↗
June 17, 2025
Frequently Asked Questions
Is Cardiff Oncology, Inc. - Common Stock publicly traded?
Yes, Cardiff Oncology, Inc. - Common Stock is publicly traded.
What exchange does Cardiff Oncology, Inc. - Common Stock trade on?
Cardiff Oncology, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Cardiff Oncology, Inc. - Common Stock?
The ticker symbol for Cardiff Oncology, Inc. - Common Stock is CRDF on the Nasdaq Stock Market
What is the current price of Cardiff Oncology, Inc. - Common Stock?
The current price of Cardiff Oncology, Inc. - Common Stock is 2.160
When was Cardiff Oncology, Inc. - Common Stock last traded?
The last trade of Cardiff Oncology, Inc. - Common Stock was at 12/04/25 04:00 PM ET
What is the market capitalization of Cardiff Oncology, Inc. - Common Stock?
The market capitalization of Cardiff Oncology, Inc. - Common Stock is 85.43M
How many shares of Cardiff Oncology, Inc. - Common Stock are outstanding?
Cardiff Oncology, Inc. - Common Stock has 85M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
|
|
|